LEVOCETIRIZINA DICLORIDRATO ( DrugBank: Levocetirizina )


1 disease
告示番号疾患名(ページ内リンク)臨床試験数
61自己免疫性溶血性貧血1

61. 自己免疫性溶血性貧血


臨床試験数 : 146 薬物数 : 131 - (DrugBank : 59) / 標的遺伝子数 : 28 - 標的パスウェイ数 : 158
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1EUCTR2020-003880-24-IT
(EUCTR)
07/06/202104/06/2021Safety, pharmacokinetics, and efficacy of subcutaneous isatuximab in adults with warm autoimmune hemolytic anemiaA multicenter, open-label, non-randomized, Phase 1b/2 study to evaluate the safety, pharmacokinetics,and efficacy of subcutaneous isatuximab in adults with warm autoimmune hemolytic anemia - . Warm autoimmune hemolytic anemia
MedDRA version: 20.0;Level: PT;Classification code 10047822;Term: Warm type haemolytic anaemia;System Organ Class: 10005329 - Blood and lymphatic system disorders;Therapeutic area: Diseases [C] - Blood and lymphatic diseases [C15]
Product Name: Montelukast
Product Code: [.]
INN or Proposed INN: MONTELUKAST
Product Name: Isatuximab
Product Code: [SAR650984]
INN or Proposed INN: Isatuximab
Product Name: Paracetamolo
Product Code: [.]
INN or Proposed INN: PARACETAMOLO
Product Name: Famotidina
Product Code: [.]
INN or Proposed INN: FAMOTIDINA
Product Name: Levocitirizina
Product Code: [.]
INN or Proposed INN: LEVOCETIRIZINA DICLORIDRATO
SANOFI-AVENTIS RECHERCHE E DEVELOPPEMENTNULLAuthorised-recruitment may be ongoing or finishedFemale: yes
Male: yes
23Phase 1;Phase 2France;United States;Hungary;Belgium;Netherlands;Germany;United Kingdom;Italy